1. Home
  2. CELU vs TACT Comparison

CELU vs TACT Comparison

Compare CELU & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celularity Inc.

CELU

Celularity Inc.

N/A

Current Price

$1.27

Market Cap

34.5M

Sector

Health Care

ML Signal

N/A

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

N/A

Current Price

$3.40

Market Cap

37.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CELU
TACT
Founded
2016
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
34.5M
37.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
CELU
TACT
Price
$1.27
$3.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$5.00
AVG Volume (30 Days)
28.0K
23.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$21.67
Revenue Next Year
$76.00
$7.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$3.22
52 Week High
$4.35
$5.70

Technical Indicators

Market Signals
Indicator
CELU
TACT
Relative Strength Index (RSI) 50.28 39.62
Support Level $1.21 $3.38
Resistance Level $1.33 $3.89
Average True Range (ATR) 0.12 0.16
MACD -0.00 -0.00
Stochastic Oscillator 45.17 21.16

Price Performance

Historical Comparison
CELU
TACT

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: